InsiderClue
Insiders · Profile

LEONARD JOHN M

President and CEO at Intellia Therapeutics · Director at IQVIA · SVP, Chief Scientific Officer at AbbVie. Filing since 8 Mar 2013. CIK 0001563584

NTLA Intellia Therapeutics, Inc. President and CEO · 29 trades IQV IQVIA Director · 1 trade ABBV AbbVie SVP, Chief Scientific Officer · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA Intellia Therapeutics, Inc.
21 Aug 2026
President and CEO
Sold on a plan
2,785
$36.21K
0.2%
NTLA Intellia Therapeutics, Inc.
20 Aug 2026
President and CEO
Sold on a plan
19,890
$250.61K
1.7%
NTLA Intellia Therapeutics, Inc.
5 Jan 2026
President and CEO
Sold at will
34,146
$314.48K
3.3%
NTLA Intellia Therapeutics, Inc.
11 Dec 2025
President and CEO
Sold on a plan
88,146
$836.38K
7.8%
NTLA Intellia Therapeutics, Inc.
3 Jan 2025
President and CEO
Sold at will
26,807
$326.51K
2.8%
NTLA Intellia Therapeutics, Inc.
3 Jan 2024
President and CEO
Sold at will
19,223
$566.31K
2.2%
NTLA Intellia Therapeutics, Inc.
4 Jan 2023
President and CEO
Sold, plan not stated
6,673
$248.30K
0.9%
NTLA Intellia Therapeutics, Inc.
1 Jan 2022
President and CEO
Sold, plan not stated
2,493
$279.85K
0.3%
NTLA Intellia Therapeutics, Inc.
1 Sep 2021
President and CEO
Sold, plan not stated
44,735
$7.60M
5.9%
NTLA Intellia Therapeutics, Inc.
31 Aug 2021
President and CEO
Sold, plan not stated
37,833
$5.86M
5.0%
NTLA Intellia Therapeutics, Inc.
30 Aug 2021
President and CEO
Sold, plan not stated
38,804
$6.05M
5.1%
NTLA Intellia Therapeutics, Inc.
23 Aug 2021
President and CEO
Sold, plan not stated
27,139
$4.13M
3.6%
NTLA Intellia Therapeutics, Inc.
19 Aug 2021
President and CEO
Sold, plan not stated
22,682
$3.43M
3.1%
NTLA Intellia Therapeutics, Inc.
1 Apr 2021
President and CEO
Sold, plan not stated
38,209
$3.20M
5.3%
NTLA Intellia Therapeutics, Inc.
9 Feb 2021
President and CEO
Sold, plan not stated
28,043
$2.10M
4.1%
NTLA Intellia Therapeutics, Inc.
5 Feb 2021
President and CEO
Sold, plan not stated
22,942
$1.55M
3.5%
NTLA Intellia Therapeutics, Inc.
3 Feb 2021
President and CEO
Sold, plan not stated
67,856
$4.92M
10.4%
NTLA Intellia Therapeutics, Inc.
1 Feb 2021
President and CEO
Sold, plan not stated
109,889
$7.03M
17.3%
NTLA Intellia Therapeutics, Inc.
5 Jan 2021
President and CEO
Sold, plan not stated
6,239
$348.51K
1.3%
NTLA Intellia Therapeutics, Inc.
27 Nov 2020
President and CEO
Sold, plan not stated
35,000
$1.35M
7.0%
NTLA Intellia Therapeutics, Inc.
25 Nov 2020
President and CEO
Sold, plan not stated
50,000
$1.80M
9.7%
NTLA Intellia Therapeutics, Inc.
16 Nov 2020
President and CEO
Sold, plan not stated
20,000
$680.00K
4.1%
NTLA Intellia Therapeutics, Inc.
4 Nov 2020
President and CEO
Sold, plan not stated
50,000
$1.30M
9.7%
NTLA Intellia Therapeutics, Inc.
7 Oct 2020
President and CEO
Sold, plan not stated
5,000
$109.15K
1.1%
NTLA Intellia Therapeutics, Inc.
1 Sep 2020
President and CEO
Sold, plan not stated
5,000
$109.15K
1.1%
NTLA Intellia Therapeutics, Inc.
6 Aug 2020
President and CEO
Sold, plan not stated
5,000
$109.15K
1.1%
NTLA Intellia Therapeutics, Inc.
1 Jul 2020
President and CEO
Sold, plan not stated
5,000
$109.15K
1.1%
NTLA Intellia Therapeutics, Inc.
3 Jun 2020
President and CEO
Sold, plan not stated
5,000
$109.15K
1.1%
IQV IQVIA
20 Dec 2019
Director
Sold, plan not stated
20,200
$3.09M
71.0%
NTLA Intellia Therapeutics, Inc.
14 May 2018
President and CEO
Sold, plan not stated
8,400
$201.60K
100%
ABBV AbbVie
15 Mar 2013
SVP, Chief Scientific Officer
Sold, plan not stated
46,700
$1.80M
30.3%
ABBV AbbVie
8 Mar 2013
SVP, Chief Scientific Officer
Sold, plan not stated
27,949
$1.05M
20.7%
32 decisions on file.